IK

Itendra Kumar Verma

Active Director Director DIN 09858403
DIN 09858403 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Itendra Kumar Verma

Data last updated:

Itendra Kumar Verma is a Director at Prickly Biotech Pharma Private Limited (since 2023). The company operates in Chemicals. Prickly Biotech Pharma Private Limited reported revenue of ₹31.6 Lakh (FY 2024).

DIN 09858403
Primary Designation Director
Industry Chemicals
First Appointment 11 Jan 2023
Oldest Company Age 3 yrs
Largest company Prickly Biotech Pharma Private Limited · ₹31.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20232023₹31.6 Lakh (FY 2024)Active

Board colleagues of Itendra Kumar Verma

Directorship timeline

Open interactive timeline →
Prickly Biotech Pharma Private Limited
Premium access

Shareholding and investment profile for Itendra Kumar Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Itendra Kumar Verma

Itendra Kumar Verma currently holds 1 directorship: Prickly Biotech Pharma Private Limited (Director, since 11 Jan 2023, revenue ₹31.6 Lakh (FY 2024)).

Itendra Kumar Verma was first appointed on 11 Jan 2023 as Director at Prickly Biotech Pharma Private Limited.

The current boards of Itendra Kumar Verma's companies include Astik Verma (Prickly Biotech Pharma Private Limited), Pammi Verma (Prickly Biotech Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available